Cart
sales@molnova.com
FHD-286
CAS No. 2671128-05-3
FHD-286( —— )
Catalog No. M28880 CAS No. 2671128-05-3
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 359 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 454 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 50MG | 760 | In Stock |
|
| 100MG | 1042 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFHD-286
-
NoteResearch use only, not for human use.
-
Brief DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
In Vitro——
-
In VivoAnimal Model:B16F10 tumor-bearing miceDosage:1.5 mg/kg Administration:Oral administration; for 10 days Result:Increased in IFNγ and Th1-type chemokine CXCL10 levels.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2671128-05-3
-
Formula Weight562.66
-
Molecular FormulaC24H30N6O6S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (444.32 mM)
-
SMILESC[C@H](C1)O[C@@H](C)CN1c1cccc(-c2csc(NC([C@H](COC)NC(c(cc3)cn3S(C)(=O)=O)=O)=O)n2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qiao J, et al. Identification of a Novel Specific Cucurbitadienol Synthase Allele in Siraitia grosvenorii Correlates with High Catalytic Efficiency. Molecules. 2019 Feb 11;24(3).
molnova catalog
related products
-
J147
J-147 is a broad spectrum neuroprotective phenyl hydrazide compound(EC50=60-115 nM) with significant neurotrophic properties related to the induction of brain-derived neurotrophic factor (BDNF).
-
PFI-1
PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM in a cell-free assay.
-
XD14
XD14 is an inhibitor of BET bromodomain (Kd of 160 nM, 170 nM, 380 nM, 490 nM, 830 nM and 850 nM for BRD4(1), BRD2(1), BRD3(1), BRD3(2), BRD2(2) and BRD4(2), respectively).
